UniSuper Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,350	Closed	-$27.5K	–	1008
2023 Q4	$27.5K	Hold	7,350	–	–	﹤0.01%	745
2023 Q3	$15.6K	Hold	7,350	–	–	﹤0.01%	742
2023 Q2	$35K	Buy	+7,350	New	+$35K	﹤0.01%	727